Pulmatrix, Inc. (PULM): Cash & Equivalents
$4.09M
As of 2025-12-31
$2.17M
As of 2026-06-30
-51.4%
3-year compound annual growth
-33.6%
5-year compound annual growth
-14.2%
10-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $4.09M | -57.1% | 2026-06-16, Balance as of period end |
| 2024-12-31 | $9.52M | -50.3% | 2026-06-16, Balance as of period end |
| 2023-12-31 | $19.17M | -46.2% | 2025-03-21, Balance as of period end |
| 2022-12-31 | $35.63M | -33.8% | 2024-03-28, Balance as of period end |
| 2021-12-31 | $53.84M | +70.1% | 2023-03-30, Balance as of period end |
| 2020-12-31 | $31.66M | +35.1% | 2022-03-29, Balance as of period end |
| 2019-12-31 | $23.44M | +814.6% | 2021-03-23, Balance as of period end |
| 2018-12-31 | $2.56M | -27.8% | 2020-03-26, Balance as of period end |
| 2017-12-31 | $3.55M | -15.1% | 2019-02-19, Balance as of period end |
| 2016-12-31 | $4.18M | -77.9% | 2018-03-13, Balance as of period end |
| 2015-12-31 | $18.90M | n/m | 2017-03-10, Balance as of period end |
| 2014-12-31 | $451.0K | n/a | 2016-03-10, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Pulmatrix, Inc. (PULM) | 2025-12-31 | $4.09M | -57.1% |
| Cadrenal Therapeutics, Inc. (CVKD) | 2025-12-31 | $4.01M | -60.0% |
| Azitra, Inc. (AZTR) | 2025-12-31 | $2.07M | -54.6% |
| Petros Pharmaceuticals, Inc. (PTPI) | 2025-12-31 | $5.14M | +198.9% |
| Polaryx Therapeutics, Inc. (PLYX) | 2025-12-31 | $5.14M | +11.3% |
| 60 Degrees Pharmaceuticals, Inc. (SXTP) | 2025-12-31 | $1.51M | -9.0% |
| AEON Biopharma, Inc. (AEON) | 2025-12-31 | $3.01M | n/m |
| CDT Equity Inc. (CDT) | 2025-12-31 | $1.51M | +172.4% |
| InMed Pharmaceuticals Inc. (INM) | 2025-06-30 | $11.08M | +68.5% |
Compare PULM, CVKD, AZTR, PTPI side by side · Screen every company in Pharmaceutical Preparations ↗